23 results
Thumbnail

D1.274 - Anaphylaxis Risks in Beekeeping: The Importance of Developing a Health Education Program

Thumbnail

D1.284 - Trends in Recurrent Anaphylaxis Triggered by Food, Drug, and Insect Allergies from 2015 to 2021: A Population-Based Retrospective Cohort Study Using the National Insurance Claims Database of Japan

Thumbnail

D1.275 - Wheat-free diet restore the normal intestinal microbiome structure in patients with wheat-dependent exercise-induced anaphylaxis

Thumbnail

D1.276 - Social #anaphylaxis: how social media reveals shifting trends in public health concerns

Thumbnail

D1.278 - Chlorhexidine allergy in perioperative anaphylaxis: undeclared and overlooked

Thumbnail

D1.279 - Vit v 5: A Chitinase Implicated in Grape-Induced Anaphylaxis

Thumbnail

D1.282 - Identification of Thaumatin-like protein (Ole E 13) as a potential allergen in green olives, a case report

Thumbnail

D1.283 - Idiopathic anaphylaxis in a child, Alpha-gal syndrome. Is it an entity in children?

Thumbnail

D1.285 - Analysis of systemic food reactions in patients sensitized to Bet v1 in Madrid (Spain)

Thumbnail

D1.286 - Nebulized inhaled epinephrine versus epinephrine autoinjector for the treatment of food-induced anaphylaxis in young children – a randomized controlled clinical trial

Thumbnail

D1.287 - Lipid profiling of Co-factor Induced Anaphylaxis: The Impact of Exercise and Aspirin on metabolism

Thumbnail

D1.289 - Severe allergy to albumin after cesarean section

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Thumbnail

D3.416 - Hereditary Alpha-Tryptasemia: A Case Series

Thumbnail

D3.417 - "Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study"